Novartis AG (NVS)

89.27
1.08 1.22
NYSE : Health Technology
Prev Close 88.19
Open 88.76
Day Low/High 88.66 / 89.42
52 Wk Low/High 74.97 / 96.31
Volume 2.95M
Avg Volume 2.22M
Exchange NYSE
Shares Outstanding 2.55B
Market Cap 223.53B
EPS 5.50
P/E Ratio 16.39
Div & Yield 1.84 (2.04%)
Starbucks Might Be About to Shock the Hell Out of Wall Street

Starbucks Might Be About to Shock the Hell Out of Wall Street

Starbucks used to be a can't miss investment. But this year the stock has languished for a variety of reasons. Wall Street could get a scary wake-up call.

Washington Uncertainty and a Healthcare Selloff Send Stocks Lower

Washington Uncertainty and a Healthcare Selloff Send Stocks Lower

Uncertainty in Washington, D.C., a healthcare sector in selloff mode and a big deals day on Wall Street sent U.S. equities lower to begin the week.

The Deal Market Still Looks Red-Hot

The Deal Market Still Looks Red-Hot

The European Central Bank may have lit a fourth quarter fire under Europe's M&A market.

Stocks Burrow Further Into the Red on Logistics of Tax Cut Plan

Stocks Burrow Further Into the Red on Logistics of Tax Cut Plan

Stocks dig further into the red on Monday, Oct. 30, as investors weigh how a proposed phase-in corporate tax rate cut might impact U.S. companies.

Merck Weighs on Dow but Apple and Tech Rally Give Lift to Nasdaq

Merck Weighs on Dow but Apple and Tech Rally Give Lift to Nasdaq

Stocks are mixed on Monday as Mueller's Russia investigation takes its first concrete steps.

Stock Futures Lower as Manafort Told to Surrender in Mueller Probe

Stock Futures Lower as Manafort Told to Surrender in Mueller Probe

Stock futures are lower on Monday as Mueller's Russia investigation takes its first concrete steps.

Novartis, Akzo Nobel and Axalta - 5 Things You Must Know Before the Market Opens

Novartis, Akzo Nobel and Axalta - 5 Things You Must Know Before the Market Opens

U.S. stock futures are lower on Monday.

Novartis To Buy Advanced Accelerator for $3.9 Billion in Oncology Push

Novartis To Buy Advanced Accelerator for $3.9 Billion in Oncology Push

Under the deal Novarits will make a cash offer of $41 a share for Nasdaq-listed AAA and $82 per American Depositary Share, subject to certain conditions, valuing AAA at $3.9 billion

Tech Bulls Can't Be Contained: Cramer's 'Mad Money' Recap (Friday 10/27/17)

Tech Bulls Can't Be Contained: Cramer's 'Mad Money' Recap (Friday 10/27/17)

Jim Cramer looks at Amazon, Alphabet, Intel and Microsoft and says his biggest problem in analyzing them is that they are such visionaries, he just can't keep up.

Baozun, J.M. Smucker Co., Southwest, Novartis: 'Mad Money' Lightning Round

Baozun, J.M. Smucker Co., Southwest, Novartis: 'Mad Money' Lightning Round

Jim Cramer is bullish on Baozun, Southwest Airlines Co., Union Pacific, CSX.

Positive Earnings Drive Dow to New Record in Best Performance in a Month

Positive Earnings Drive Dow to New Record in Best Performance in a Month

Powerhouse performances from Caterpillar and 3M inspire a Dow rally, leading the index to new all-time highs in its 54th record close of the year.

Dow Rises 200 Points With Records in Grasp After Caterpillar, 3M Earnings

Dow Rises 200 Points With Records in Grasp After Caterpillar, 3M Earnings

Better-than-expected earnings from a number of key Dow components sweep markets higher.

Solid Quarters From Caterpillar, 3M Drive Dow to Intraday Records

Solid Quarters From Caterpillar, 3M Drive Dow to Intraday Records

Better-than-expected earnings from a number of key Dow components sweep markets higher.

A Burst of Earnings Keeps Premarket Trade Busy, Stock Futures Rise

A Burst of Earnings Keeps Premarket Trade Busy, Stock Futures Rise

U.S. stock futures are higher on Tuesday, Oct. 24, looking to partially recover from losses seen a day earlier that swept benchmark indexes from record levels.

McDonald's, Sears and Amazon - 5 Things You Must Know Before the Market Opens

McDonald's, Sears and Amazon - 5 Things You Must Know Before the Market Opens

U.S. stock futures are rising on Tuesday, after Wall Street's record-breaking streak came to an end during the previous trading session.

How to Manage GE Risk and the Netflix-Disney Fight: Market Recon

How to Manage GE Risk and the Netflix-Disney Fight: Market Recon

Entering GE too early has its costs, but there are ways to mitigate them.

Amazon, Novartis and Netflix - This is What You Need to Know on Tuesday

Amazon, Novartis and Netflix - This is What You Need to Know on Tuesday

European markets opened flat as investors await the European Central Bank meeting

Novartis Tops Estimates Boosted by New Drugs

Novartis Tops Estimates Boosted by New Drugs

The company is also undertaking a strategic review of its Alcon eye care business and said Tuesday that it indicates that creating a stand-alone company via a capital markets exit could create additional shareholder value.

Gilead Stock Climbs as FDA Approves Lymphoma Cancer Therapy Drug Yescarta

Gilead Stock Climbs as FDA Approves Lymphoma Cancer Therapy Drug Yescarta

The drug is anticipated to rake in $1.7 billion in worldwide sales in the next five years with a U.S. list price of $373,000.

European Stocks Euphoria Is Running High ... Maybe Too High

European Stocks Euphoria Is Running High ... Maybe Too High

European stock markets are priced almost to perfection ahead of an earnings deluge.

FDA Advisory Committee Greenlights First Gene Therapy for Inherited Disorder

FDA Advisory Committee Greenlights First Gene Therapy for Inherited Disorder

Spark Therapeutics gains gene therapy advisory OK for treatment restoring some sight for patients facing eventual blindness.

Las Vegas Shooting Holds Headlines While Stocks Jump to New Records

Las Vegas Shooting Holds Headlines While Stocks Jump to New Records

Stocks look past the worst mass shooting in U.S. history on Monday, Oct. 2, to trade at new records.

Stocks Trade at Records Again Even as Las Vegas Shooting Death Toll Rises

Stocks Trade at Records Again Even as Las Vegas Shooting Death Toll Rises

Stocks look past the worst gun shooting in U.S. history on Monday, Oct. 2, to trade at new records.

Stocks at Records as U.S. Manufacturing Conditions Improve

Stocks at Records as U.S. Manufacturing Conditions Improve

Stocks begin the new month and quarter with gains on Monday, Oct. 2, as manufacturing conditions hold in expansion territory for another month.

Novartis CEO Joe Jimenez to Step Down in 2018

Novartis CEO Joe Jimenez to Step Down in 2018

Novartis CEO Joe Jimenez will step down next year to make room for chief medical officer Vas Narasimhan.

FDA Greenlights Novartis' Gene Therapy for Leukemia

FDA Greenlights Novartis' Gene Therapy for Leukemia

Novartis' Kymriah is the first gene therapy approved by the FDA.

Novartis' CAR-T Gene Therapy Receives FDA Approval

Novartis' CAR-T Gene Therapy Receives FDA Approval

The treatment is the first of its kind to be authorized in the U.S.

StoneMor Shares Have Fallen Like a Stone

But even at this low level, the stock is no bargain.

Novartis AG, Sirius XM Radio, Coupa Software: 'Mad Money' Lightning Round

Novartis AG, Sirius XM Radio, Coupa Software: 'Mad Money' Lightning Round

Jim Cramer is bullish on Novartis AG, Sirius XM Radio, Coupa Software and Juno Therapeutics.

August's Inexplicable Selloffs Are Here: Cramer's 'Mad Money' Recap (8/17/17)

August's Inexplicable Selloffs Are Here: Cramer's 'Mad Money' Recap (8/17/17)

Jim Cramer says the calendar and the momentum holders are coalescing to produce selling. Here's what investors should do about it.

TheStreet Quant Rating: A- (Buy)